In 2022, the market for gene editing in oil and gas was estimated to be worth USD 50.4 million.
The market for gene editing in oil and gas is anticipated to increase at a CAGR of 16.20% from 2023 to 2030, reaching USD 167.52 million in 2030.
Cancer treatment is the most popular biomedical research and therapeutics category.
Crop modification by agriculture and crop improvement is the notable segment.
The biofuel production category is anticipated to exhibit the highest CAGR during the projection period.